Eisai's Scientific Advisory Group (SAG) to Meet and Review lecanemab's Marketing Authorization Application in the EU
The Scientific Advisory Group (SAG) will meet to examine the marketing authorization application (MAA) for Lecanemab, also known as LEQEMBI®, in the European Union (EU), according to a…









